Related Experiment Video
Updated: Sep 20, 2026

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
Published on: March 30, 2014
Highly active antiretroviral therapy in resource-poor settings: the experience of Médecins Sans Frontières
Jean-Michel Tassie1, Elisabeth Szumilin, Alexandra Calmy
1Epicentre, Paris, France.
Abstract:
We describe the short-term results of highly active antiretroviral therapy (HAART) in seven projects in low and middle income countries. A total of 743 adults were included, and clinical, immunological and virological responses were analysed. At 6 months, outcomes were similar to those observed in western countries, and the probability of remaining on treatment was 94%. The challenge now is to extend access to HAART to the millions in urgent need.
Related Concept Videos
Retrovirus Life Cycles
Therapeutic Drug Monitoring: Affecting Factors
Sexually Transmitted Infections
Cryptococcal Meningitis
Antiviral Nucleoside Inhibitors
Subviral Agents

